Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

FDA Mandates Black Box Warning On Older Antipsychotics

Posted by Jane Akre
Tuesday, June 17, 2008 11:25 AM EST
Category: Major Medical, Protecting Your Family
Tags: Antipsychotics, Zyprexa, FDA and Prescription Drugs, Dangerous Drugs

FDa to mandate black box warning on older antipsychotics. 

LEARN MORE

   

IMAGE SOURCE: ©iStockPhoto/ elderly woman/ author: Silva Jansen

 

 

The FDA is trying out its new teeth.

The agency was given the authority to mandate drug warnings by the Amendments Act of 2007. Previously the FDA could only request the manufacturer comply.

In the first demonstration of its new authority, the Food and Drug Administration is ordering makers of older antipsychotics, such as thorazine and prolixin, to carry a new black box warning alerting physicians of their dangers.

The drugs are sometimes used to treat seniors with dementia and behavioral problems, although not approved for that use.

Manufacturers will receive letters mandating them to update their labels with the black box or stronger labels, warning about an increase in the risk of death among elderly given the drugs.

The class of drugs targeted are the so-called conventional antipsychotics, and also include Navane (Pfizer), and Moban (Endo Pharmaceuticals). 

The newer class of drugs, atypical antipsychotics, such as Zyprexa (Eli Lilly & Co.) and Risperdal (Johnson & Johnson), already received the stronger warning labels in 2005, alerting the public about the potential for heart attack and pneumonia when given to the  elderly with dementia.

Observational studies show the conventional antipsychotics carry the same risk as atypical antipsychotics.

Seniors in nursing homes with dementia sometimes exhibit psychotic symptoms such as agitation, delusions and hallucinations. They can be aggressive and violent. The antipsychotics are used to quell those symptoms.

Convention and atypical antipsychotics work by blocking the dopamine action in the brain.

In an interview with reporters, Dr. Thomas Laughren of the FDA’s Division of Psychiatry Products said that when the agency looked at data involving atypical antipsychotics, it found that after 10 weeks, nearly half of the patients with dementia died, compared to 2.6 percent on a placebo.

The patients, in their 80s were already sickened by cancer or infections.

A study by Canadian researchers, published last month, found that the elderly with dementia were more than three times likely to die when given atypical antipsychotics, when compared to those who had been given no drug therapy.

The black box warning doesn’t mean doctors cannot prescribe the conventional antipsychotics to those sickened by dementia.

"What we want to do is make them aware of this risk. This is something we hope they would discuss with the families and caregivers so they can understand that there are risks to using these drugs,” says Laughren to the Washington Post. #


1 Comment

Posted by Daniel Haszard
Wednesday, June 18, 2008 1:24 AM EST

Eli Lilly Zyprexa RICO Lawsuit
"Through a complex series of illegal rackets and lies, Eli Lilly drug company built a multi-billion dollar drug enterprise at the expense of taxpayers, consumers and patient lives".
Zyprexa remains on the market in the United States and more than 80 other countries. About 30 state attorneys general have subpoenaed documents detailing Lilly's sales practices for Zyprexa as part of a civil investigation under state consumer protection laws.

Zyprexa qualifies for a MedGuide warning:


(1) The labeling would definitely help prevent serious adverse events;
(2) Few patients would be willing to take the drug and risk developing diabetes given that numerous studies have shown Zyprexa to be no more effective than the older class of antipsychotics that do not cause diabetes; and
(3) Most patients on Zyprexa would learn that the drug is not FDA approved to treat the condition they have.
---

Daniel Haszard LINK

HERE LINK Connecticut Sues Lilly Over Zyprexa (this is a RICO lawsuit like they use against organized crime)

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes